Management of chemotherapy induced emesis
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently. To prevent acute emesis induced by cisplatin, moderately e...
Main Author: | Roila Fausto |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Oncology, Sremska Kamenica, Serbia
2004-01-01
|
Series: | Archive of Oncology |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-7310/2004/0354-73100403173R.pdf |
Similar Items
-
Management of chemotherapy induced emesis
by: Roila Fausto
Published: (2004-01-01) -
Assessment of the Adherence Rate of Acute Chemotherapy Induced Nausea and Vomiting Prophylaxis Regimens by Medical Team to NCCN Clinical Recommendations: Cross-Section Observation
by: Mohammad Mohammadzadeh, et al.
Published: (2021-04-01) -
Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section — a randomized control trial
by: Sylvanus Kampo, et al.
Published: (2019-09-01) -
Prophylactic antiemetic effects in gynecologic patients receiving fentanyl IV-patient controlled analgesia: comparison of combined treatment with ondansetron and dexamethasone with metoclopramide and dexamethasone
by: Young Seok Jee, et al.
Published: (2010-11-01) -
Study of Metoclopramide Versus Metoclopramide Plus Dexamethasone for Reduction of Nausea & Vomiting after Maxillomandibular Fixation Surgery
by: Farhad Heshmati, et al.
Published: (2002-03-01)